Possible Mechanism of Inhibition of Experimental Pulmonary Metastasis of Mouse Colon Adenocarcinoma 26 Sublines by a Sialic Acid:Nucleoside Conjugate

Cancer Research

Volumn 48, Issue 13, 1988, Pages 3728-3732

  Kijima Suda, Isao ^a   Miyazawa, Takeshi ^a   Itoh, Masayoshi ^a   Toyoshima, Satoshi ^a   Osawa, Toshiaki ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b MECT Corporation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5' O (4 ACETAMIDO 3,6,7,8 TETRA O ACETYL 2,4 DIDEOXY 1 METHOXYCARBONYL GLYCERO ALPHA GALACTO OCTAPYRANOSYL) 5 FLUORO 2',3' ISOPROPYLIDENEURIDINE; ANTIMETASTATIC AGENT; PLATELET DERIVED GROWTH FACTOR; SIALIC ACID; SIALIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; COLON CARCINOMA; LUNG METASTASIS; METASTASIS POTENTIAL; NONHUMAN;

ANIMAL; CELL ADHESION; CELL DIVISION; GLYCOSIDES; INSULIN; MEMBRANE PROTEINS; MICE; NEOPLASM METASTASIS; NEURAMINIDASE; PHOSPHORYLATION; PLATELET AGGREGATION; PLATELET-DERIVED GROWTH FACTOR; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; URIDINE;

EID: 0023759440     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Marbry, E. W., and Carubelli, R. Sialic acid in human cancer. Experientia (Basel), 28:182-183, 1972.
2. Bryant, M. L., Stoner, G. P., and Metzger, R. P. Protein-bound carbohydrate
3. content of normal and tumorous human lung tissue. Biochim. Biophys. Acta, 343:226-231,1974.
4. Tao, T-W., and Burgar, M. M. Non-metastasizing variants selected from metastasizing melanoma cells. Nature (Lond.), 270:437-438,1977.
5. Beraacki, R. J. Concomitant elevations in serum sialyltransferase activity and sialic acid in rats with metastasizing mammary tumors. Science (Wash. DC), 195:577-580,1977.
6. Yogeeswaran, B., Stein, B. S., and Sebastian, H. Altered cell surface organization of gangliosides and sialylglycoproteins of mouse metastatic melanoma variant lines selected in vivo for enhanced lung implantation. Cancer Res., 38:1336-1344,1978.
7. Yogeeswaran, G., Sebastian, H., and Stein, B. S. Cell surface sialylation of glycoproteins and glycosphingolipids in cultured metastatic variant RNA-virus transformed non-producer BALB/c 3T3 cell lines. Int. J. Cancer, 24: 193-202,1979.
8. Skipski, V. P., Carter, S. P., Terebus-keldsh, O. I., Podlasld, F. J., Jr., Peterson, R. H. F., and Stock, C. C. Ganglioside profiles of metastases and of metastasizing and nonmetastasizing rat primary mammary carcinomas. J. Natl. Cancer Inst., 67:1251-1258,1981.
9. Yogeeswaran, G., and Salk, P. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science (Wash. DC), 212:1514-1516,1981.
10. Fogel, M., Altevogt, P., and Schirrmacher, V. Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation. J. Exp. Med., 157:371-376,1983.
11. Bosnian, H. B., Bieber, G. F., Brown, A. E., Case, K. R., Gersten, D. M., Kimmer, T. W., and Lione, A. Biochemical parameters correlated with tumor cell implantation. Nature (Lond.), 246:487-489,1983.
12. Kjjima-Suda, I., Toyoshima, S., Itoh, M., Furuhata, K., Ogura, H., and Osawa, T. Inhibition of sialyltransferase of murine lymphocytes by disaccharide nucleosides. Chem. Pharm. Bull., 33:730-739,1985.
13. Kijjima-Suda, I., Miyamoto, Y., Toyoshima, S., Itoh, M., and Osawa, T. Inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid: nucleoside conjugate having sialyltransferase inhibiting activity. Cancer Res., 46:858-862,1986.
14. Gasic, G., Gasic, T., and Stewart, C. C. Anti-metastatic effects associated with platelet reduction. Proc. Natl. Acad. Sci. USA, 61:46-52,1968.
15. Gasic, G., Gasic, T., Galanti, N., Johnson, T., and Murphy, S. Platelet-tumor cell interactions in mice. The role of platelets in the spread of malignant disease. Int. J. Cancer, 11:704-708,1973.
16. Karpatkin, S., and Pearlstein, E. Role of platelets in tumor cell metastasis. Ann. Intern. Med., 95:636-641,1981.
17. Kjjima, I., Ezawa, K., Tayoshima, S., Furuhata, K., Ogura, H., and Osawa, T. Induction of suppressor T cells by neuraminic acid derivatives. Chem. Pharm. Bull., 30:3278-3283,1982.
18. Tsuruo, T., Yamori, T., Naganuma, K., Tsukagoshi, S., and Sakurai, Y. Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26. Cancer Res., 43:5437-5442,1983.
19. Dennis, J., Waller, C., Timpl, R., and Schirrmacher, V. Surface sialic acid reduces attachment of metastatic tumor cells to collagen type IV and fibronectin. Nature (Lond.), 300:274-276,1982.
20. Mohanty, D., and Hilgard, P. A new platelet aggregating material (PAM) in an experimental induced rat fibrosarcoma. Thromb. Haemostas. (Stuttgart), 51:192-195,1984.
21. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with Folin phenol reagent J. Biol. Chem., 193:265-275,1951.
22. Nishimura, J., Huang, J. S., and Deuel, T. F. Platelet-derived growth factor stimulates tyrosine-specific protein kinase activity in Swiss mouse 3T3 cell membranes. Proc. Natl. Acad. Sci. USA, 79:4303-4307,1982.
23. Laemli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227:680-685,1970.
24. Steck, T. L., and Wallach, D. F. H. The binding of lddney-bean phytohemagglutinin by Ehrlich ascites carcinoma. Biochim. Biophys. Acta, 97:510-522,1965.
25. Yogeeswaran, G., Fujinami, R., Kiessling, R., and Welsh, R. M. Interferon induced alteration in sialic acid and glycoconjugates of L-919 cells. Virology, 121:363-371,1982.
26. Pearlstein, E., Cooper, L. B., and Karpatkin, S. Extraction and characterization of a platelet-aggregating material from SV40-transformed mouse 3T3 fibroblasts. J. Lab. Clin. Med., 93:332-344,1979.
27. Hara, Y., Steiner, M., and Baldini, M. G. Characterization of the platelet-aggregating activity of tumor cells. Cancer Res., 40:1217-1222,1980.
28. Karpatkin, S., Smerling, A., and Pearlstein, E. Plasma requirement for the aggregation of rabbit platelet by an aggregating material derived from SV 40-transformed 3T3 fibroblasts. J. Lab. Clin. Med., 96:994-1001,1980.
29. Glenn, K., Brown-Pope, D. F., and Ross, R. Platelet-derived growth factor. III. Identification of platelet-derived growth factor receptor by affinity labeling. J. Biol. Chem., 257:5172-5176,1982.
30. Heldin, C-H., Ek, B., and Ronnstrand, L. Characterization of one receptor for platelet-derived growth factor on human fibroblasts. J. Biol. Chem., 258: 10054-10061,1983.
31. Tsuruo, T., Kawabata, H., Iida, H., and Yamori, T. Tumor-induced platelet aggregation and growth promoting factors as determinants for successful tumor metastasis. Clin. Exp. Metastasis, 4:25-34,1986.